In developing HCC, TGF-β acts as a suppressor in the early stage, but once HCC cells escape from its cyto-inhibitory effect, it leads to later tumor progression as part of its potential tumorigenic effect (16, 17). This evidence concerns the gene TGFB1 and neoplasm.